References
- 1. World Health Organization. The World Health Report. World Health Organization, 2002.
- 2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.10.1002/ijc.2921025220842
- 3. Peeters PJHL, Bazelier MT, Leufkens HGM, de Vries F, De Bruin ML. The risk of colorectal cancer in patients with type 2 diabetes: associations with treatment stage and obesity. Diabetes Care. 2015 Mar;38(3):495–502.10.2337/dc14-117525552419
- 4. Leopa N, Dumitru A, Mitroi A, Tocia C, Popescu R. Colorectal cancer in patients with diabetes mellitus. Rom J Diabetes Nutr Metab Dis. 2021;28(1):47–53.
- 5. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010; 28:573–62110.1146/annurev-immunol-030409-101225462004020192811
- 6. Wang R, Leong RW. Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: a review of the literature. World J Gastroenterol. 2014 Jul;20(27):8783–9.
- 7. Crohn BB, Rosenberg H: The sigmoidoscopic picture of chronic ulcerative colitis (non-specific). Am J Med Sci 1925, 170:220-22810.1097/00000441-192508010-00006
- 8. Larsen M, Mose H, Gislum M, Skriver MV, Jepsen P, Norgard B, Sorensen HT. Survival after colorectal cancer in patients with Crohn’s disease: A nationwide population-based Danish follow-up study. Am J Gastroenterol 2007; 102: 163-16710.1111/j.1572-0241.2006.00857.x17037994
- 9. Neumann H, Vieth M, Langner C, Neurath MF, Mudter J. Cancer risk in IBD: how to diagnose and how to manage DALM and ALM. World J Gastroenterol. 2011 Jul;17(27):3184–91.
- 10. Freeman HJ. Colorectal cancer complicating Crohn’s disease. Can J Gastroenterol 2001; 15: 231-23610.1155/2001/93473411331924
- 11. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst. 2005 Nov;97(22):1679–87.10.1093/jnci/dji37516288121
- 12. Stahl TJ, Schoetz DJ, Roberts PL, Coller JA, Murray JJ, Silverman ML, Veidenheime MC: Crohn’s disease and carcinoma: increasing justification for surveillance. Dis Colon Rectum 1992, 35:850-85610.1007/BF020478721511645
- 13. Korelitz Bl, Lauwers GY, Sommers SC: Rectal mucosal dysplasia in Crohn’s disease. Gut 1990, 31:1382-1386.10.1136/gut.31.12.138213787612265778
- 14. Beaugerie L, Itzkowitz SH. Cancers complicating inflammatory bowel disease. N Engl J Med. 2015;372(15):1441–52.10.1056/NEJMra140371825853748
- 15. Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis. 2017;11(6):649–70.10.1093/ecco-jcc/jjx00828158501
- 16. Kang EA, Han K, Chun J, Soh H, Park S, Im JP, Kim JS. Increased Risk of Diabetes in Inflammatory Bowel Disease Patients: A Nationwide Population-Based Study in Korea. Journal of Clinical Medicine. 2019; 8(3):343.10.3390/jcm8030343646326330862129
- 17. Abdalla M, Landerholm K, Andersson P, Andersson RE, Myrelid P. Risk of Rectal Cancer After Colectomy for Patients With Ulcerative Colitis: A National Cohort Study. Clin Gastroenterol Hepatol. 2017 Jul;15(7):1055-1060.e2.10.1016/j.cgh.2016.11.03628013111